About Hopital Claude Huriez; Sce Dermatologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hopital Claude Huriez; Sce Dermatologie
During the past decade, Hopital Claude Huriez; Sce Dermatologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-04-01
2014-12-01
Completed
3,222
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
2001-11-01
2004-12-01
Completed
240
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
2002-11-01
Completed
250
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
2003-08-01
2011-12-01
Completed
12,537
A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy
2001-11-01
2007-01-01
Completed
83
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization
2002-02-01
2007-02-01
Completed
4,726
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
2002-10-01
2006-12-01
Completed
20,506
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
2003-08-01
Completed
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hopital Claude Huriez; Sce Dermatologie
According to Clinical.Site data, the most researched conditions in "Hopital Claude Huriez; Sce Dermatologie" are
"Basal Cell Carcinoma" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Melanoma" (1 trials) and "Metastatic Melanoma" (1 trials). Many other conditions were trialed in "Hopital Claude Huriez; Sce Dermatologie" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Claude Huriez; Sce Dermatologie
Most popular intervention types in "Hopital Claude Huriez; Sce Dermatologie" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Cobimetinib" (2 trials), "Pembrolizumab" (2 trials), "Atezolizumab" (1 trials), "RO6874281" (1 trials) and "Vemurafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Claude Huriez; Sce Dermatologie
The vast majority of trials in "Hopital Claude Huriez; Sce Dermatologie" are
5 trials for "All" genders.
Clinical Trials Status at Hopital Claude Huriez; Sce Dermatologie
Currently, there are NaN active trials in "Hopital Claude Huriez; Sce Dermatologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hopital Claude Huriez; Sce Dermatologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Claude Huriez; Sce Dermatologie, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".